{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:37:39Z","timestamp":1770341859066,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bordeaux and Region Aquitaine"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neuropharm.2016.10.007","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T10:24:54Z","timestamp":1476527094000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"PA","title":["Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors"],"prefix":"10.1016","volume":"113","author":[{"given":"A.","family":"Simonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zamberletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-3091","authenticated-orcid":false,"given":"S.","family":"Caill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.10.007_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s002130000676","article-title":"Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats","volume":"155","author":"Baker","year":"2001","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib2","article-title":"The role of the habenula in nicotine addiction","volume":"S1","author":"Baldwin","year":"2011","journal-title":"J.\u00a0Addict. Res. Ther."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hipo.22272","article-title":"Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice","volume":"24","author":"Basavarajappa","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ntr\/ntq244","article-title":"Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort","volume":"13","author":"Bolam","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.10.007_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005353.pub3","article-title":"Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0028-3908(02)00118-1","article-title":"Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence","volume":"43","author":"Castane","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib8","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00213-013-3367-3","article-title":"Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice","volume":"231","author":"Ceci","year":"2014","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib9","doi-asserted-by":"crossref","first-page":"e28142","DOI":"10.1371\/journal.pone.0028142","article-title":"Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition","volume":"6","author":"Cippitelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib10","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/npp.2012.67","article-title":"Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.npp.1300541","article-title":"Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)","volume":"30","author":"Cohen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/nn1210-1446","article-title":"Anandamide serves two masters in the brain","volume":"13","author":"Di Marzo","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00213-009-1569-5","article-title":"Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration\u2013comparison with CB(1) receptor blockade","volume":"205","author":"Forget","year":"2009","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00213-016-4232-y","article-title":"Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats","volume":"233","author":"Forget","year":"2016","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00213-005-0015-6","article-title":"Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats","volume":"181","author":"Forget","year":"2005","journal-title":"Psychopharmacol. (Berl)"},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2016.10.007_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.09.008","article-title":"Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability","volume":"76","author":"Fowler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature09797","article-title":"Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake","volume":"471","author":"Fowler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1476-5381.2011.01440.x","article-title":"The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake","volume":"164","author":"Gamaleddin","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0269881113477710","article-title":"AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking","volume":"27","author":"Gamaleddin","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib21","doi-asserted-by":"crossref","first-page":"e29900","DOI":"10.1371\/journal.pone.0029900","article-title":"Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking","volume":"7","author":"Gamaleddin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonzalez","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib23","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1073\/pnas.1313103110","article-title":"Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons","volume":"110","author":"Gorlich","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in\u00a0vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/14622200701243185","article-title":"Depression during tobacco abstinence","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib26","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/npp.2015.62","article-title":"Effects of fatty acid amide hydrolase (FAAH) inhibitors in non-human primate models of nicotine reward and relapse","volume":"40","author":"Justinova","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pnpbp.2013.10.009","article-title":"Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach","volume":"52","author":"Le Foll","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/ejn.12480","article-title":"The lateral habenula in addiction and depression: an anatomical, synaptic and behavioral overview","volume":"39","author":"Lecca","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature09742","article-title":"Synaptic potentiation onto habenula neurons in the learned helplessness model of depression","volume":"470","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib31","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1240729","article-title":"betaCaMKII in lateral habenula mediates core symptoms of depression","volume":"341","author":"Li","year":"2013","journal-title":"science"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2008.12.037","article-title":"Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas","volume":"1257","author":"Marco","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib33","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2010.07.009","article-title":"Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors","volume":"69","author":"Mascia","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","article-title":"Cannabinoids and emotionality: a neuroanatomical perspective","volume":"204","author":"McLaughlin","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib36","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.1523\/JNEUROSCI.3221-08.2008","article-title":"Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors","volume":"28","author":"Melis","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/jpet.108.138321","article-title":"The endogenous cannabinoid system modulates nicotine reward and dependence","volume":"326","author":"Merritt","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2011.08.046","article-title":"Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?","volume":"204","author":"Moreira","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.lfs.2012.05.015","article-title":"The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence","volume":"92","author":"Muldoon","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib40","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2013.157","article-title":"Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine","volume":"38","author":"Navarrete","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2014.04.014","article-title":"The dual blocker of FAAH\/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis","volume":"87","author":"Navarria","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.106.105270","article-title":"Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats","volume":"320","author":"O'Dell","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopsych.2015.11.009","article-title":"Effects of smoking cessation on presynaptic dopamine function of addicted male smokers","volume":"80","author":"Rademacher","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib44","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1523\/JNEUROSCI.3149-13.2014","article-title":"Nicotine self-administration induces CB1-dependent LTP in the bed nucleus of the stria terminalis","volume":"34","author":"Reisiger","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/en.2009-0862","article-title":"Plasma transcortin influences endocrine and behavioral stress responses in mice","volume":"151","author":"Richard","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib46","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1046\/j.1471-4159.2000.0752478.x","article-title":"Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats","volume":"75","author":"Rubino","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib47","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.biopsych.2009.08.027","article-title":"Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient","volume":"67","author":"Sartorius","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuropharm.2016.07.024","article-title":"PPARalpha modulation of mesolimbic dopamine transmission rescues depression-related behaviors","volume":"110","author":"Scheggi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib49","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/jpet.108.142224","article-title":"Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats","volume":"327","author":"Scherma","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1369-1600.2012.00476.x","article-title":"Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area","volume":"18","author":"Simonnet","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbb.2006.07.014","article-title":"Long-term changes in fear conditioning and anxiety-like behavior following nicotine exposure in adult versus adolescent rats","volume":"85","author":"Smith","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuron.2015.08.035","article-title":"Habenular CB1 Receptors Control the Expression of Aversive Memories","volume":"88","author":"Soria-G\u00f3mez","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biopsych.2012.12.019","article-title":"Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving","volume":"73","author":"Theberge","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.10.007_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbr.2010.07.034","article-title":"Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression","volume":"216","author":"Winter","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/bph.12500","article-title":"Long-term consequences of perinatal fatty acid amino hydrolase inhibition","volume":"171","author":"Wu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbr.2007.10.022","article-title":"Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus","volume":"188","author":"Yang","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.10.007_bib56","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/ncomms7770","article-title":"Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal","volume":"6","author":"Zhao-Shea","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816304579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816304579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T11:09:36Z","timestamp":1617620976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816304579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":57,"alternative-id":["S0028390816304579"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}